Literature DB >> 19717971

Cisd2 mediates mitochondrial integrity and life span in mammals.

Yi-Fan Chen1, Cheng-Heng Kao, Ralph Kirby, Ting-Fen Tsai.   

Abstract

CISD2, the causative gene for Wolfram syndrome 2 (WFS2), is a previously uncharacterized novel gene. Using a mouse genetic approach, this work demonstrated for the first time that Cisd2 is involved in mammalian life span control. Cisd2 deficiency in mice leads to mitochondrial breakdown and dysfunction; this is accompanied by cell death with autophagic features and these events precede the two earliest manifestations of nerve and muscle degeneration. Together, they lead to a panel of phenotypic features suggestive of premature aging. This work effectively links Cisd2 gene function, mitochondrial integrity and aging in mammals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19717971     DOI: 10.4161/auto.5.7.9351

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  24 in total

1.  Mutation of the His ligand in mitoNEET stabilizes the 2Fe-2S cluster despite conformational heterogeneity in the ligand environment.

Authors:  Andrea R Conlan; Mark L Paddock; Christina Homer; Herbert L Axelrod; Aina E Cohen; Edward C Abresch; John A Zuris; Rachel Nechushtai; Patricia A Jennings
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-05-17

2.  Light-induced release of nitric oxide from the nitric oxide-bound CDGSH-type [2Fe-2S] clusters in mitochondrial protein Miner2.

Authors:  Yiming Wang; Jeonghoon Lee; Huangen Ding
Journal:  Nitric Oxide       Date:  2019-05-28       Impact factor: 4.427

3.  CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.

Authors:  Bin Chen; Shunli Shen; Jian Wu; Yunpeng Hua; Ming Kuang; Shaoqiang Li; Baogang Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  CISD2 expression is a novel marker correlating with pelvic lymph node metastasis and prognosis in patients with early-stage cervical cancer.

Authors:  Luxin Liu; Meng Xia; Jing Wang; Weijing Zhang; Yanna Zhang; Mian He
Journal:  Med Oncol       Date:  2014-08-20       Impact factor: 3.064

Review 5.  Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.

Authors:  Sweta Shah; Marc Marie Dooms; Sofia Amaral-Garcia; Mariana Igoillo-Esteve
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

6.  Disrupting CISD2 function in cancer cells primarily impacts mitochondrial labile iron levels and triggers TXNIP expression.

Authors:  Ola Karmi; Yang-Sung Sohn; Sara I Zandalinas; Linda Rowland; Skylar D King; Rachel Nechushtai; Ron Mittler
Journal:  Free Radic Biol Med       Date:  2021-09-20       Impact factor: 7.376

7.  CDGSH iron sulfur domain 2 mitigates apoptosis, oxidative stress and inflammatory response caused by oxygen-glucose deprivation/reoxygenation in HT22 hippocampal neurons by Akt-Nrf2-activated pathway.

Authors:  Xiaoyan Ren; Jiangang Yu; Lili Guo; Zaili Zhang
Journal:  Metab Brain Dis       Date:  2022-07-12       Impact factor: 3.655

8.  Dysregulation of Mitochondrial Functions and Osteogenic Differentiation in Cisd2-Deficient Murine Induced Pluripotent Stem Cells.

Authors:  Ping-Hsing Tsai; Yueh Chien; Jen-Hua Chuang; Shih-Jie Chou; Chian-Hsu Chien; Ying-Hsiu Lai; Hsin-Yang Li; Yu-Lin Ko; Yuh-Lih Chang; Chen-Ying Wang; Yung-Yang Liu; Hsin-Chen Lee; Chang-Hao Yang; Ting-Fen Tsai; Yi-Yen Lee; Shih-Hwa Chiou
Journal:  Stem Cells Dev       Date:  2015-08-10       Impact factor: 3.272

9.  Exploring the FMN binding site in the mitochondrial outer membrane protein mitoNEET.

Authors:  Homyra Tasnim; Aaron P Landry; Chelsey R Fontenot; Huangen Ding
Journal:  Free Radic Biol Med       Date:  2020-05-20       Impact factor: 7.376

10.  Behavioral characterization of a novel Cisd2 mutant mouse.

Authors:  Christiann H Gaines; Angela E Snyder; Robin B Ervin; Joseph Farrington; Kenneth Walsh; Sarah A Schoenrock; Lisa M Tarantino
Journal:  Behav Brain Res       Date:  2021-02-18       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.